ArticleNeuro-oncology advances

A single-arm phase 2 study of abemaciclib in adult patients with recurrent grade 3 oligodendroglioma.

Carson A Wills et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.